
Loading, please wait...

Loading, please wait...

CONKO-001 evaluated the role of adjuvant gemcitabine after curative-intent resection for pancreatic cancer. The study became an important reference point because recurrence after apparently successful pancreatic surgery is common, reflecting both local and systemic microscopic disease. Long-term follow-up showed a clear improvement in disease-free survival with adjuvant gemcitabine compared with observation. The study helped establish postoperative systemic therapy as an essential part of management after pancreatic resection rather than viewing surgery as definitive treatment on its own. For surgeons, the key implication is that the quality of resection and postoperative recovery must be aligned with timely access to systemic therapy. Pancreaticoduodenectomy and other pancreatic operations carry substantial physiological stress, so nutritional optimization, complication prevention and coordinated postoperative care can directly affect whether patients are able to proceed with adjuvant treatment. CONKO-001 also illustrates the importance of long-term follow-up in surgical oncology. Early perioperative success does not capture the real therapeutic objective when recurrence remains common. Modern pancreatic cancer care therefore integrates surgery, pathology, systemic therapy, imaging and multidisciplinary review from the outset, with the resection serving as one critical step in a longer oncological pathway.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


CONKO-001 evaluated the role of adjuvant gemcitabine after curative-intent resection for pancreatic cancer. The study became an important reference point because recurrence after apparently successful pancreatic surgery is common, reflecting both local and systemic microscopic disease. Long-term follow-up showed a clear improvement in disease-free survival with adjuvant gemcitabine compared with observation. The study helped establish postoperative systemic therapy as an essential part of management after pancreatic resection rather than viewing surgery as definitive treatment on its own. For surgeons, the key implication is that the quality of resection and postoperative recovery must be aligned with timely access to systemic therapy. Pancreaticoduodenectomy and other pancreatic operations carry substantial physiological stress, so nutritional optimization, complication prevention and coordinated postoperative care can directly affect whether patients are able to proceed with adjuvant treatment. CONKO-001 also illustrates the importance of long-term follow-up in surgical oncology. Early perioperative success does not capture the real therapeutic objective when recurrence remains common. Modern pancreatic cancer care therefore integrates surgery, pathology, systemic therapy, imaging and multidisciplinary review from the outset, with the resection serving as one critical step in a longer oncological pathway.
last month

A study demonstrates an explainable machine learning framework integrating clinical and echocardiographic metrics to predict left atrial appendage thrombus in non-valvular atrial fibrillation, utilizing SHAP analysis for clinical interpretability.
2 days back

A systematic review and transcriptomic cross-study consensus analysis illuminates the role of necroptosis in cervical cancer. By promoting anti-tumor immunogenicity and resolving apoptosis resistance, necroptotic pathways offer actionable prognostic signatures and promising avenues for combination immunotherapy.
Yesterday

Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
Last week

A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
Last week

Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
Last week